Skip to main content
Clinical Trials/NCT00782977
NCT00782977
Completed
Not Applicable

Oxygenation Via Nasal Cannulae Prevents Arterial Hypoxemia During the Apneic Period in Paralyzed Patients

University of Manitoba1 site in 1 country90 target enrollmentNovember 2008
ConditionsHypoxia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypoxia
Sponsor
University of Manitoba
Enrollment
90
Locations
1
Primary Endpoint
PaO2 in mmHg (arterial oxygen tension as measured by an arterial blood gas)
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of the study is to evaluate the effectiveness of continuous oxygen provided by nasal prongs in preventing or delaying hypoxemia during the apneic period that occurs after induction of general anesthesia. This will be evaluated by measuring the arterial oxygen tension (PaO2).

The study will also evaluate whether there is any difference in PaO2 when using nasal prongs with flow rates of 5 L/minute versus 10 L/minute of oxygen.

Detailed Description

Certain patient populations are at risk for rapid desaturation and the rapid development of hypoxemia (eg. morbidly obese and pregnant patients). Using pulse oximetry, it has already been shown that oxygen provided with a catheter inserted into the nasopharynx is effective in delaying the desaturation that occurs with apnea before the trachea is intubated. It has also been shown that apneic oxygenation with nasal prongs at 5 L/min during fibreoptic intubation can delay the onset of hypoxemia. The study will evaluate whether there is any significant difference in the PaO2 (arterial oxygen tension, as measured by an arterial blood gas) when nasal prongs are used to provide apneic oxygenation in paralyzed patients at flows of 5 L/min compared to 10 L/min. The study aims to demonstrate that apneic oxygenation using nasal prongs is effective in preventing or delaying hypoxemia (by measuring PaO2), and that this technique may be used to prevent morbidity and mortality in all clinical areas (not only in the Operating Room environment) where airway management is undertaken.

Registry
clinicaltrials.gov
Start Date
November 2008
End Date
December 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy males and females
  • ASA Class 1-3
  • Ages of 18 to 65
  • Elective surgery under general anesthesia
  • No evidence of significant cardiac, respiratory or gastrointestinal disease
  • No contraindications to the insertion of a radial arterial catheter

Exclusion Criteria

  • Evidence of a difficult airway (expected difficult intubation identified from patient history or clinical examination)
  • Features suggestive of difficult bag mask ventilation
  • Significant GERD requiring medical therapy
  • Significant respiratory disease (including severe asthma or COPD, oxygen dependency, pulmonary hypertension)
  • Significant cardiac disease (ischemic heart disease, severe aortic and mitral stenosis and/or regurgitation, EF \< 50% if known)
  • Inability to lie flat (skeletal deformities, orthopnea, congestive cardiac failure)
  • PaO2 \< 200 mmHg on ABG after adequate preoxygenation to an ETO2 \> 85%
  • Hemoglobin \< 100 g/L
  • BMI \> 40 kg/ m2
  • Patient unwillingness or refusal to participate

Outcomes

Primary Outcomes

PaO2 in mmHg (arterial oxygen tension as measured by an arterial blood gas)

Time Frame: Arterial blood gases taken at one minute intervals post induction in the apneic period, for a total of 4 measurements

Study Sites (1)

Loading locations...

Similar Trials